Steven M. Smith

3.4k total citations · 1 hit paper
113 papers, 2.2k citations indexed

About

Steven M. Smith is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Surgery. According to data from OpenAlex, Steven M. Smith has authored 113 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Cardiology and Cardiovascular Medicine, 28 papers in Endocrinology, Diabetes and Metabolism and 18 papers in Surgery. Recurrent topics in Steven M. Smith's work include Blood Pressure and Hypertension Studies (46 papers), Hormonal Regulation and Hypertension (17 papers) and Sodium Intake and Health (16 papers). Steven M. Smith is often cited by papers focused on Blood Pressure and Hypertension Studies (46 papers), Hormonal Regulation and Hypertension (17 papers) and Sodium Intake and Health (16 papers). Steven M. Smith collaborates with scholars based in United States, United Kingdom and Australia. Steven M. Smith's co-authors include Rhonda M. Cooper‐DeHoff, George L. Bakris, Carl J. Pepine, John G. Gums, David A. Calhoun, Haesuk Park, Katy E. Trinkley, Eric Judd, Christopher Newton‐Cheh and Samuel S. Gidding and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Steven M. Smith

101 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Resistant Hypertension: Detection, Evaluation, and Management: A Scientific Statement From the American Heart Association

2018 655 citations David A. Calhoun, Steven M. Smith et al. Hypertension profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven M. Smith United States	23	1.1k	627	354	352	249	113	2.2k
Jan Basile United States	28	1.8k 1.7×	949 1.5×	548 1.5×	377 1.1×	238 1.0×	150	3.0k
Blas Gil Extremera Spain	22	1.2k 1.1×	366 0.6×	357 1.0×	362 1.0×	144 0.6×	80	2.5k
Giorgio Gentile Italy	25	1.0k 0.9×	439 0.7×	426 1.2×	175 0.5×	110 0.4×	97	2.2k
Brian Rayner South Africa	31	951 0.9×	1.0k 1.6×	482 1.4×	262 0.7×	145 0.6×	139	3.3k
Marion R. Wofford United States	22	1.3k 1.2×	858 1.4×	356 1.0×	292 0.8×	274 1.1×	37	3.3k
Hilary Wynne United Kingdom	28	690 0.6×	551 0.9×	293 0.8×	335 1.0×	416 1.7×	76	3.5k
Adam P. Bress United States	26	1.5k 1.4×	386 0.6×	294 0.8×	267 0.8×	99 0.4×	130	2.5k
Dena Ettehad United Kingdom	4	1.7k 1.5×	464 0.7×	342 1.0×	387 1.1×	81 0.3×	4	2.4k
Grégoire Wuerzner Switzerland	26	1.1k 1.0×	535 0.9×	358 1.0×	204 0.6×	87 0.3×	155	2.4k
Jorge Polónia Portugal	30	1.8k 1.6×	240 0.4×	298 0.8×	478 1.4×	205 0.8×	181	3.2k

Countries citing papers authored by Steven M. Smith

Since Specialization

Citations

This map shows the geographic impact of Steven M. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Smith more than expected).

Fields of papers citing papers by Steven M. Smith

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Smith. The network helps show where Steven M. Smith may publish in the future.

Co-authorship network of co-authors of Steven M. Smith

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Smith. A scholar is included among the top collaborators of Steven M. Smith based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Smith. Steven M. Smith is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Winterstein, Almut G., Matthew J. Gurka, Anne M. Libby, et al.. (2025). Disparities in Initial Antihypertensive Intensity by Sex, Race and Ethnicity in Newly Treated Patients With Hypertension. American Journal of Hypertension. 38(8). 560–569.

Choi, Jaeyoung, M.-C. Calvet, Carl J. Pepine, et al.. (2025). High‐Throughput Screening for Prescribing Cascades Among Real‐World Angiotensin‐ II Receptor Blockers ( ARBs ) Initiators. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 45(11). 729–740.

Smith, Steven M., et al.. (2024). Characterizing apparent treatment resistant hypertension in the United States: insights from the All of Us Research Program. Journal of the American Medical Informatics Association. 31(12). 2899–2907. 3 indexed citations

Allen, John M., Hui Shao, William T. Donahoo, et al.. (2024). Geographic variation and racial disparities in adoption of newer glucose-lowering drugs with cardiovascular benefits among US Medicare beneficiaries with type 2 diabetes. PLoS ONE. 19(1). e0297208–e0297208. 10 indexed citations

McDonough, Caitrin W., Steven M. Smith, Yan Gong, et al.. (2024). Integrated metabolomics analysis reveals mechanistic insights into variability in blood pressure response to thiazide diuretics and beta blockers. Clinical and Translational Science. 17(5). e13816–e13816. 1 indexed citations

Desai, Raj, et al.. (2024). Comparative Safety of Long‐Acting vs. Short‐Acting Erythropoiesis‐Stimulating Agents Among Patients Undergoing Hemodialysis. Clinical Pharmacology & Therapeutics. 116(1). 217–224. 1 indexed citations

Winterstein, Almut G., Matthew J. Gurka, Anne M. Libby, et al.. (2024). Initial Antihypertensive Prescribing in Relation to Blood Pressure Among Florida Medicaid and Medicare Recipients in the OneFlorida+ Research Consortium. Hypertension. 81(2). e7–e9.

Allen, John M., et al.. (2022). Impact of Piperacillin-Tazobactam Dosing in Septic Shock Patients Using Real-World Evidence: An Observational, Retrospective Cohort Study. Annals of Pharmacotherapy. 57(6). 653–661. 1 indexed citations

Tang, Huilin, Stephen E. Kimmel, Steven M. Smith, et al.. (2022). Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials. Diabetes Care. 45(4). 1007–1012. 10 indexed citations

10.

Desai, Raj, Haesuk Park, Joshua D. Brown, Rajesh Mohandas, & Steven M. Smith. (2022). Norepinephrine reuptake inhibitors and risk of antihypertensive treatment intensification and major adverse cardiovascular events in patients with stable hypertension and depression. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 42(6). 472–482. 3 indexed citations

11.

Smith, Steven M., Almut G. Winterstein, Matthew J. Gurka, et al.. (2022). Initial Antihypertensive Regimens in Newly Treated Patients: Real World Evidence From the OneFlorida+ Clinical Research Network. Journal of the American Heart Association. 12(1). e026652–e026652. 14 indexed citations

12.

Smith, Steven M., et al.. (2021). Effectiveness of sacubitril/valsartan versus aldosterone antagonists in heart failure with reduced ejection fraction: A retrospective cohort study. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(9). 710–721.

13.

Dawwas, Ghadeer K., Charles E. Leonard, Scott Martin Vouri, et al.. (2020). Twelve‐year trends in pharmacologic treatment of type 2 diabetes among patients with heart failure in the United States. Diabetes Obesity and Metabolism. 22(4). 705–710. 3 indexed citations

14.

Desai, Raj, Eric Dietrich, Haesuk Park, & Steven M. Smith. (2020). Out-of-Pocket Payment for Ambulatory Blood Pressure Monitoring Among Commercially Insured in the United States. American Journal of Hypertension. 33(11). 999–1002. 6 indexed citations

15.

Hwang, Andrew Y. & Steven M. Smith. (2020). U.S. trends in prescription nonsteroidal anti‐inflammatory drug use among patients with cardiovascular disease, 1988–2016. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 41(3). 247–256. 8 indexed citations

16.

McDonough, Caitrin W., Steven M. Smith, Rhonda M. Cooper‐DeHoff, & William R. Hogan. (2019). Optimizing Antihypertensive Medication Classification in Electronic Health Record-Based Data: Classification System Development and Methodological Comparison. JMIR Medical Informatics. 8(2). e14777–e14777. 12 indexed citations

17.

Smith, Steven M., Matthew J. Gurka, Almut G. Winterstein, Carl J. Pepine, & Rhonda M. Cooper‐DeHoff. (2019). Incidence, prevalence, and predictors of treatment‐resistant hypertension with intensive blood pressure lowering. Journal of Clinical Hypertension. 21(6). 825–834. 17 indexed citations

18.

Dietrich, Eric, et al.. (2019). Reimbursement of ambulatory blood pressure monitoring in the US commercial insurance marketplace. Journal of Clinical Hypertension. 22(1). 6–15. 12 indexed citations

19.

Smith, Steven M. & Rhonda M. Cooper‐DeHoff. (2018). Fixed-Dose Combination Amlodipine/Celecoxib (Consensi) for Hypertension and Osteoarthritis. The American Journal of Medicine. 132(2). 172–174. 13 indexed citations

20.

Smith, Steven M., Matthew J. Gurka, David A. Calhoun, et al.. (2018). Optimal Systolic Blood Pressure Target in Resistant and Non-Resistant Hypertension: A Pooled Analysis of Patient-Level Data from SPRINT and ACCORD. The American Journal of Medicine. 131(12). 1463–1472.e7. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact